Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Rathmann

Showing results (1-10 of 413) with videos related to

Pageof 42
Sort By:
Journal of Diabetes and Its Complications|February 8, 2017
Association of dipeptidyl peptidase 4 inhibitors with risk of metastases in patients with type 2 diabetes and breast, prostate or digestive system cancerWolfgang Rathmann, Karel Kostev
Diabetologia|February 17, 2021
Pharmacogenetics of novel glucose-lowering drugsWolfgang Rathmann, Brenda Bongaerts
Gerontology|May 15, 2022
Combined Effects of Diabetes and Education on Decline of Cognitive Performance in the Older Population: The Survey of Health, Ageing, and Retirement in EuropeBernd Kowall, Wolfgang Rathmann
Acta Diabetologica|September 6, 2022
Correction to: Association of glucose‑lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer databaseWolfgang Rathmann, Karel Kostev
Diabetologia|February 7, 2025
Partnership and marriage and risk of type 2 diabetes: a narrative reviewBernd Kowall, Wolfgang Rathmann
Acta Diabetologica|August 6, 2022
Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer databaseWolfgang Rathmann, Karel Kostev
Acta Diabetologica|November 7, 2019
A missed protective drug-drug interaction of DPP-4 inhibitors and statins on myopathy riskOliver Kuss, Wolfgang Rathmann
Acta Diabetologica|April 2, 2024
Reply to comment on: Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyser databaseWolfgang Rathmann, Karel Kostev
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 24, 2024
Type 2 diabetes incidence in patients initiating denosumab or alendronate treatment: a primary care cohort studyWolfgang Rathmann, Karel Kostev
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 19, 2013
HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?Bernd Kowall, Wolfgang Rathmann
Pageof 42

Showing results (1-10 of 413) with videos related to

Sort By:
Pageof 42
Journal of Diabetes and Its Complications|February 8, 2017
Association of dipeptidyl peptidase 4 inhibitors with risk of metastases in patients with type 2 diabetes and breast, prostate or digestive system cancerWolfgang Rathmann, Karel Kostev
Diabetologia|February 17, 2021
Pharmacogenetics of novel glucose-lowering drugsWolfgang Rathmann, Brenda Bongaerts
Gerontology|May 15, 2022
Combined Effects of Diabetes and Education on Decline of Cognitive Performance in the Older Population: The Survey of Health, Ageing, and Retirement in EuropeBernd Kowall, Wolfgang Rathmann
Acta Diabetologica|September 6, 2022
Correction to: Association of glucose‑lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer databaseWolfgang Rathmann, Karel Kostev
Diabetologia|February 7, 2025
Partnership and marriage and risk of type 2 diabetes: a narrative reviewBernd Kowall, Wolfgang Rathmann
Acta Diabetologica|August 6, 2022
Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer databaseWolfgang Rathmann, Karel Kostev
Acta Diabetologica|November 7, 2019
A missed protective drug-drug interaction of DPP-4 inhibitors and statins on myopathy riskOliver Kuss, Wolfgang Rathmann
Acta Diabetologica|April 2, 2024
Reply to comment on: Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyser databaseWolfgang Rathmann, Karel Kostev
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 24, 2024
Type 2 diabetes incidence in patients initiating denosumab or alendronate treatment: a primary care cohort studyWolfgang Rathmann, Karel Kostev
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 19, 2013
HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?Bernd Kowall, Wolfgang Rathmann
Pageof 42